Concepedia

Publication | Open Access

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen‐independent prostate carcinoma

27

Citations

18

References

2004

Year

Abstract

This regimen of EMP plus weekly paclitaxel was an active and well tolerated treatment for patients with AIPC.

References

YearCitations

Page 1